QuidelOrtho Explodes: 40% Increase After Earnings Release
Reading Time: 2 minutes
QuidelOrtho Corporation is a global leader in the field of in-vitro diagnostics based in the USA. Formed from the merger of Quidel Corporation and Ortho Clinical Diagnostics in May 2022, the company combines over 80 years of experience in developing and manufacturing diagnostic solutions. With a broad product portfolio that includes brands such as Sofia®, QuickVue®, VITROS®, and Savanna®, QuidelOrtho serves various areas like molecular diagnostics, clinical chemistry, and transfusion medicine. The company employs approximately 7,100 people worldwide...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
